$CNO

CNO Financial (CNO) officer plans $244K stock sale

CNO Financial Group (CNO) officer Jeremy Williams plans to sell 4,420 shares, valued at $244,291.63, on September 15, 2026, following a stock option exercise. The sale is under Rule 144, which governs insider stock sales.

Original reporting
Published Sep 15, 2026, 8:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 9:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CNO
Neutral
high confidence
Mentioned
$CNO
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CNONeutralLow
01

Why it matters

The filing adds a modest amount of shares to the market, likely causing negligible price movement.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

Potential dilution from the option exercise and any future insider sales could cumulatively affect share supply.

Relevance 4/10Novelty 3/10Timing: transaction date September 15, 2026

Background

CNO Financial Group disclosed a Rule 144 filing for a planned insider sale by an officer.

Company-level read

Ticker impact

$CNONeutralHigh confidence
Context

Officer Jeremy Williams filed a Rule 144 notice to sell 4,420 CNO shares valued at $244,291.63 on September 15, 2026.

Expected impact

Minimal short‑term price pressure; unlikely to move the stock materially.

Evidence & confidence

The transaction size is under $250k and represents a routine option exercise, so market impact is expected to be negligible.

Market effects

No material effect on the financial services sector; typical insider sales are routine.

Limited to U.S. investors tracking CNO; no broader regional impact.

None

Counterpoint

If the officer is cashing out, it could hint at undisclosed concerns, but the small size makes this speculative.

Key entities

  • Jeremy Williams

    CNO Financial Group officer filing the Rule 144 notice.

  • CNO Financial Group, Inc.

    Issuer of the shares being sold.

Related articles

$CNOMed

CNO Financial Group (CNO) Beats In Q2 But Is The Rally Already Priced In

CNO Financial Group (CNO) reported Q2 revenue beating expectations, with operating earnings per share up 45% and 16 consecutive quarters of sales growth. The stock is up 30.19% year-to-date and 42.14% over one year. However, it is slightly overvalued according to a narrative fair value of $53.50. Growth is driven by annuity and life/health policy sales, digital channels, and an aging U.S. population. Risks include low long-term interest rates and rising long-term care claims.

$CNOMed

California Nanotechnologies Posts 28% Revenue Growth in Q1 FY2027 as Nuclear Pivot Takes Hold

California Nanotechnologies (TSXV:CNO) reported Q1 FY2027 revenue of $917,854, up 28% from $716,553 a year earlier, for the quarter ended May 31, 2026. Adjusted EBITDA loss narrowed to $129,031 from $152,707, while net loss was $449,598. The company attributes growth to customer diversification and a nuclear supply-chain pivot tied to initial SMR component purchase orders.

$CNOHighAI 9/10

CNO Financial (CNO) Q2 2026 Earnings Call Transcript

CNO Financial Group (NYSE:CNO) reported Q2 2026 operating EPS of $1.26, up 45% year over year, and net operating income of $119.5 million. Total new annualized premiums rose 7% to a record. Full-year EPS guidance was raised to $4.60 to $4.80. The company also repurchased $60 million of shares.

$CNOMed

CNO Financial posts insurance income gain on 16-quarter sales streak

CNO Financial Group reported Q2 2026 sales growth for a 16th consecutive quarter. Insurance policy income rose to $680.7 million from $651.3 million a year earlier, and net income increased to $125.9 million, or $1.33 per diluted share, from $91.8 million, or $0.91. CNO raised full-year 2026 operating EPS guidance by 8% at the midpoint and estimated RBC at 377% as of June 30.

$CNOMed

CNO Financial Group’s (NYSE:CNO) Q2 CY2026 Sales Beat Estimates

Insurance services company CNO Financial Group (NYSE: CNO) announced better-than-expected revenue in Q2 CY2026, with sales up 34.6% year on year to $1.29 billion. Its GAAP profit of $1.33 per share was 36.4% above analysts’ consensus estimates. Is now the time to buy CNO Financial Group? Find out by accessing our full research report, it’s free.

$CNOLow

CNO Financial Group, Inc. (CNO): Results of Operations and Financial Condition

CNO Financial Group, Inc. (CNO) filed an SEC Form 8-K — Results of Operations and Financial Condition. News For Immediate Release CNO Financial Group Reports Second Quarter 2026 Results Carmel, Ind., July 30, 2026 - CNO Financial Group, Inc. (NYSE: CNO) today reported its second quarter 2026 financial results: • Strong execution and momentum continues; Raising 2026 operating earni